Abstract
Pyroglutamate-modified amyloid-β (Aβ) at amino acid position three (AβpE3–42) is gaining considerable attention as a potential key player in the pathogenesis of Alzheimer's disease (AD). AβpE3–42 is abundant in AD brain and has a high aggregation propensity, stability, and cellular toxicity. The aim of the present work was to study the effect of AβpE3–42 expression on neuron loss and associated behavioral deficits using the TBA42 transgenic mouse model. Expression of pyroglutamate Aβ3–42 triggers hippocampal CA1 neuron loss and behavioral deficits in the TBA42 mouse model. Mice elicited significant neuron death (−35% at the age of 12 months), deficits in the spatial reference memory, working memory, loss of anxiety, and severe motor deficits in an age-dependent manner. These results support a major pathological function of pyroglutamate Aβ in AD.
Keywords
Get full access to this article
View all access options for this article.
